May 19th: PharmaTech- Future Forward

​PharmaTech is optimizing pharma value capture, from discovery to supply chain and beyond. It’s the engine translating breakthrough science into patient-centric, scalable, data-driven innovation. On May 19th, join thought leaders and budget owners from GSK, Microsoft and Venture Capital firms aMoon, Grove Ventures and Entree Bio. See you at "PharmaTech: Future Forward", 10am-12pm, Naschitz Brandes & Amir law firm, 5 Tuval Street, Tel Aviv. Details:

​
Date: Tuesday, May 19th
Time: 10am-12pm
Agenda:
Opening Remarks: Noga Spira, Partner, Naschitz, Brandes, Amir; MNC Perspectives: Lena Granovsky, Head of Israel R&D site Senior Director, AI ML, GSK Pharma; Ksenya Kveler, Principal Medical Science Manager, Health AI, Microsoft
Investors Roundtable: Roy Wiesner, Partner, aMoon; Yael Gruenbaum-Cohen, PhD, General Partner, Entree Bio; Renana Ashkenazi, Managing Partner, Grove Ventures
Moderator: Ellie Hanson, FINN Partners

​Join the leaders shaping the next chapter in pharma and tech convergence: Tuesday, May 19th, 5 Tuval Street, Tel Aviv.